Notably, we found that the impaired glycolytic activity as shown by reduced ECAR in LDHA-depleted glioblastoma cells was negated by the treatment with EVs from EMφ, but not LDHA-depleted EMφ (Fig. 5j). This evidence concerns the gene LDHA and glioblastoma.